March 10, 2026

Science Chronicle

A Science and Technology Blog

March 10, 2026

Science Chronicle

A Science and Technology Blog

Vaccine hesitancy

ImmunisationVaccine hesitancyVaccinesZero-dose children

Can India reduce the number of zero-dose children by half in five years?

With a staggering 1.44 million zero-dose children in 2023, and only about nearly reaching the 2019 level of 1.4 million, can India reduce the number of zero-dose children by half of the 2019 level by 2030 to meet the IA2030 target?

Read More
COVID-19HealthResearchVaccine hesitancyVaccines

ICMR study finds the drivers of COVID-19 vaccine hesitancy

Of the 600 participants studied, 524 (87.3%) had taken only one dose of the COVID-19 vaccine, while the remaining 76

Read More
Clinical trialCoronavirusPublic health policySARS-CoV-2Vaccine hesitancyVaccines

Vaccinate all above 45 years to avoid vaccine inequities

Roping in the private sector to support the government programme of vaccinating about 270 million people belonging to the two

Read More
CoronavirusICMRPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Covaxin has only 10% takers nationally; less than 1% uptake in 12 States, Union Territories

On January 3, the Indian regulator approved Covaxin for restricted use “under clinical trial mode” as a matter of “abundant

Read More
CoronavirusPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Daily vaccination rate will soon increase exponentially, says task force member

On January 16, when the mass COVID-19 vaccination programme began in India, only 3,352 sessions were held and 0.19 million

Read More
CoronavirusPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Glitches in CoWIN also responsible for low COVID-19 vaccine uptake

On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking

Read More
Clinical trialCoronavirusPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing

Read More
Clinical trialCoronavirusCOVID-19Public HealthSARS-CoV-2Vaccine hesitancyVaccines

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use.

Read More
ChinaCoronavirusCOVID-19EthicsPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Why Russia’s rushed-up coronavirus vaccine is mired in ethical, safety landmine

  Russia registering a vaccine for novel coronavirus even before beginning a Phase-3 trial and promising to  begin full-scale production

Read More
CDCHealthMeaslesPublic HealthVaccine hesitancyVaccinesWorld Health Organisation

Measles cases continue to increase globally since 2016

There has been a 59% drop in measles cases between 2000 and 2018. Yet, since 2016, there has been a

Read More
Communicable diseaseHealthMeaslesPublic HealthVaccine hesitancyVaccinesWorld Health Organisation

Infants become susceptible to measles earlier than thought

In countries that have eliminated or nearly eliminated measles, maternal antibodies against the virus have been found to protect infants

Read More
AutismCDCHealthMeaslesPublic HealthVaccine hesitancyVaccinesWorld Health Organisation

What led to spread of measles for nearly a year in New York

Though measles vaccine coverage is high in the U.S., the reason why the two outbreaks in New York City and

Read More